Model
Edge
Acura Pharmaceuticals, Inc
0001416145
Filing Type
4
Filing Date
8/4/2022
Updated
8/5/22, 10:17 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership